Church & Dwight
This article was originally published in The Tan Sheet
Executive Summary
Firm will pay approximately $254 mil. to purchase Kelso & Co.'s 50% interest in Armkel, with the sale expected to close around May 30, the Princeton, N.J.-based company announces May 6. Purchase is expected to have a negative impact on C&D's second and third quarter earnings, but likely will be accretive by early 2005, the firm says. C&D acquired Armkel in a 50/50 joint venture with Kelso in 2001. The firm predicts Q1 diluted net income per share will increase 40% to $.70 per share and revenue will rise 19% to $296 mil., boosted by a longer quarter and the recent acquisition of Unilever's North American oral care business. First quarter results will be announced May 11...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.